$0.3590
0.007802.22%
At close: -
$0.3600
0.001000.28%
After Hours: Apr 17, 4:23 PM EDT
Comments
Loading...
Aethlon Medical Analyst Ratings and Price Targets | NASDAQ:AEMD | Benzinga
Aethlon Medical Inc has a consensus price target of $7 based on the ratings of 2 analysts. The high is $7 issued by HC Wainwright & Co. on March 10, 2025. The low is $7 issued by HC Wainwright & Co. on March 10, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 10, 2025, February 19, 2025, and January 30, 2025, respectively. With an average price target of $7 between HC Wainwright & Co., there's an implied 1844.44% upside for Aethlon Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Aethlon Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | Buy Now | 1844.44% | HC Wainwright & Co. | Vernon Bernardino49% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 1844.44% | HC Wainwright & Co. | Vernon Bernardino49% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2025 | Buy Now | 1844.44% | HC Wainwright & Co. | Vernon Bernardino49% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2024 | Buy Now | 1844.44% | HC Wainwright & Co. | Vernon Bernardino49% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | 1844.44% | HC Wainwright & Co. | Vernon Bernardino49% | $10 → $7 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | 2677.78% | HC Wainwright & Co. | Vernon Bernardino49% | $23 → $10 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 6288.89% | HC Wainwright & Co. | Vernon Bernardino49% | $90 → $23 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | — | Maxim Group | Anthony Vendetti63% | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Aethlon Medical (AEMD) stock?
The latest price target for Aethlon Medical (NASDAQ:AEMD) was reported by HC Wainwright & Co. on March 10, 2025. The analyst firm set a price target for $7.00 expecting AEMD to rise to within 12 months (a possible 1844.44% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aethlon Medical (AEMD)?
The latest analyst rating for Aethlon Medical (NASDAQ:AEMD) was provided by HC Wainwright & Co., and Aethlon Medical reiterated their buy rating.
When was the last upgrade for Aethlon Medical (AEMD)?
There is no last upgrade for Aethlon Medical
When was the last downgrade for Aethlon Medical (AEMD)?
The last downgrade for Aethlon Medical Inc happened on November 15, 2022 when Maxim Group changed their price target from N/A to N/A for Aethlon Medical Inc.
When is the next analyst rating going to be posted or updated for Aethlon Medical (AEMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
Is the Analyst Rating Aethlon Medical (AEMD) correct?
While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a reiterated with a price target of $7.00 to $7.00. The current price Aethlon Medical (AEMD) is trading at is $0.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
